Status:

RECRUITING

Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Lead Sponsor:

Novo Nordisk A/S

Conditions:

Obesity

Overweight

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This study will look at how much cagrilintide helps people with overweight or obesity lower their body weight. Cagrilintide is a new investigational medicine. Doctors may not yet prescribe cagrilintid...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study
  • Female or male (sex at birth)
  • Age 18 years or above at the time of signing the informed consent
  • History of at least one self-reported unsuccessful dietary effort to lose body weight (a\*)
  • Body mass index (BMI) greater than or equal to \>= 30.0 kilogram per square meter (kg/m\^2), or BMI greater than or equal to \>= 27.0 kg/m\^2 with the presence of at least one weight related comorbidity including, but not limited to, hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease (a\*)
  • Exclusion criteria:
  • History of type 1 or type 2 diabetes (a\*)
  • Treatment, or intention to initiate treatment, with any medication prescribed for the indication of weight management within 180 days before screening (a\*)
  • Previous dosing of marketed or non-marketed amylin-based compounds (a\*) (a\*) - As declared by the participant, reported in the medical records or at the investigator's discretion.

Exclusion

    Key Trial Info

    Start Date :

    November 5 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 14 2027

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT07220642

    Start Date

    November 5 2025

    End Date

    July 14 2027

    Last Update

    December 23 2025

    Active Locations (40)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 10 (40 locations)

    1

    Diablo Clinical Research, Inc.

    Walnut Creek, California, United States, 94598

    2

    Univ of Colorado at Denver

    Aurora, Colorado, United States, 80045

    3

    Florida Inst For Clin Res LLC

    Orlando, Florida, United States, 32825

    4

    Oviedo Medical Research, LLC

    Oviedo, Florida, United States, 32765

    Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide | DecenTrialz